Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles

• Main Authors: Shingo Nakamura (Author), Masanori Fujita (Author), Yasutaka Mori (Author), Hidemi Hattori (Author), Megumi Takikawa (Author), Masayuki Ishihara (Author), Satoko Kishimoto (Author)
• Format: Book
• Published: MDPI AG, 2012-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Low-molecular-weight heparin/protamine microparticles (LMW-H/P MPs) were produced as a carrier for heparin-binding growth factors (GFs) and for various adhesive cells. A mixture of low-molecular-weight heparin (MW: approximately 5000 Da, 6.4 mg/mL) and protamine (MW: approximately 3000 Da, 10 mg/mL)...